Revealing of metabolic alterations in primary fibroblasts of patients with Neurodegeneration with Brain Iron Accumulation - subtype MPAN

IF 4.2 2区生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Biochimica et biophysica acta. Molecular basis of disease Pub Date : 2024-09-16 DOI:10.1016/j.bbadis.2024.167383

Agata Wydrych , Barbara Pakula , Patrycja Jakubek , Justyna Janikiewicz , Aneta M. Dobosz , Agnieszka Cudna , Agnieszka Antos , Maciej Rydzewski , Maciej Cwyl , Mariola Popielarz , Karolina Pierzynowska , Lidia Gaffke , Zuzanna Cyske , Estera Rintz , Grzegorz Wegrzyn , Paolo Pinton , Werner J.H. Koopman , Marta Skowronska , Iwona Kurkowska-Jastrzebska , Agnieszka Dobrzyn , Mariusz R. Wieckowski

引用次数: 0

查看原文本刊更多论文

揭示脑铁蓄积性神经变性亚型 MPAN 患者原代成纤维细胞的代谢变化

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biochimica et biophysica acta. Molecular basis of disease 生物-生化与分子生物学

CiteScore

12.30

自引率

0.00%

发文量

218

审稿时长

32 days

期刊介绍： BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.